Latest News in the pharma Industry

Policy & Regulation

FDA Expands Use of Prevnar 13 Vaccine

FDA Expands Use of Prevnar 13 Vaccine

4 Jan 2012

The new use for Prevnar 13 was approved under the agency's accelerated approval pathway, which allows for earlier approval of treatments for serious and life-threatening illnesses.

Read more 
XARELTO Application Submitted to U.S. FDA

XARELTO Application Submitted to U.S. FDA

30 Dec 2011

Janssen Research & Development, LLC has submitted a supplemental New Drug Application to the FDA seeking approval for the use of anticoagulant XARELTO.

Read more 
Perrigo Gets FDA Final Approval for Desloratadine

Perrigo Gets FDA Final Approval for Desloratadine

28 Dec 2011

Perrigo has received final approval from the FDA for its ANDA for Desloratadine tablets.

Read more 
French Regulator Clears United Therapeutics’ Remodulin for PAH Therapy

French Regulator Clears United Therapeutics’ Remodulin for PAH Therapy

28 Dec 2011

The clearance follows a review period during which 22 EU member states endorsed the final variation assessment report issued by AFSSAPS.

Read more 
India's Commerce Ministry Decides to Extend 2nd Phase of Barcoding Implementation

India's Commerce Ministry Decides to Extend 2nd Phase of Barcoding Implementation

26 Dec 2011

The second phase of barcoding will become mandatory from July 1, 2012 along with the third phase of barcoding on primary level packaging.

Read more 
HMPC to Strengthen Integration of Herbal Medicines in Pharmaceutical Legislative Framework

HMPC to Strengthen Integration of Herbal Medicines in Pharmaceutical Legislative Framework

23 Dec 2011

A work programme for 2012-2015 aims to strengthen the integration of herbal medicines in the pharmaceutical legislative framework.

Read more 
FDA Accepts New Drug Application for Tofacitinib

FDA Accepts New Drug Application for Tofacitinib

23 Dec 2011

The FDA has accepted a new drug application for tofacitinib for review.

Read more 
Santarus Submits NDA for UCERIS Tablets

Santarus Submits NDA for UCERIS Tablets

21 Dec 2011

UCERIS is being developed in collaboration with Cosmo Technologies. Upon acceptance for review of the NDA for UCERIS Tablets, $4 million is payable to Cosmo.

Read more 
EMA Issues Revised Guidance on Genotoxicity Testing of Medicines

EMA Issues Revised Guidance on Genotoxicity Testing of Medicines

20 Dec 2011

The revised guideline sets out the state of the art in genotoxicity testing and is expected to improve the assessment of the risks of human medicines.

Read more 
EMA Recommends Approval of Vimpat Syrup

EMA Recommends Approval of Vimpat Syrup

19 Dec 2011

Once approved by the European Commission, the 10-mg/ml syrup will provide a new treatment option that can be taken by mouth by patients who have difficulty swallowing tablets.

Read more 
India's OPPI Urges DoP to Reconsider Price Regulation on APIs

India's OPPI Urges DoP to Reconsider Price Regulation on APIs

19 Dec 2011

OPPI urges the reconsideration of para 4(2) recommendation that price regulation would not apply to any upstream products such as bulk drugs and intermediates.

Read more 
Gilead Submits sNDA to FDA for Truvada

Gilead Submits sNDA to FDA for Truvada

16 Dec 2011

If the sNDA is approved, Truvada would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex, a prevention approach called PrEP.

Read more